Cited Publications

Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses.

Transcatheter aortic valves (TAVs) are a promising treatment for high risk surgical patients suffering from degeneration of previously implanted bioprostheses (valve-in-valve therapy).

Go to the Article

Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.